T 0215/12 of 22.10.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T021512.20151022
- Date of decision
- 22 October 2015
- Case number
- T 0215/12
- Online on
- 20 April 2016
- Petition for review of
- -
- Application number
- 05700976.3
- IPC class
- A61K 47/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DIRECT COMPRESSION FORMULATION AND PROCESS
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Teva Pharmaceutical Industries Ltd.
KRKA, d.d., Novo mesto - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)European Patent Convention Art 113(1)European Patent Convention R 106European Patent Convention Art 56
- Keywords
- Late-filed documents
Late-filed document - admitted (no)
Obligation to raise objections - objection dismissed
Inventive step - all requests (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appellants' objection in respect of a procedural defect under Rule 106 EPC is dismissed.
2. The appeal is dismissed.